跳转至内容
Merck
CN
  • An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension.

An endothelial apelin-FGF link mediated by miR-424 and miR-503 is disrupted in pulmonary arterial hypertension.

Nature medicine (2012-12-25)
Jongmin Kim, Yujung Kang, Yoko Kojima, Janet K Lighthouse, Xiaoyue Hu, Micheala A Aldred, Danielle L McLean, Hyekyung Park, Suzy A Comhair, Daniel M Greif, Serpil C Erzurum, Hyung J Chun
摘要

Pulmonary arterial hypertension (PAH) is characterized by vascular remodeling associated with obliteration of pulmonary arterioles and formation of plexiform lesions composed of hyperproliferative endothelial and vascular smooth-muscle cells. Here we describe a microRNA (miRNA)-dependent association between apelin (APLN) and fibroblast growth factor 2 (FGF2) signaling in pulmonary artery endothelial cells (PAECs). APLN deficiency in these cells led to increased expression of FGF2 and its receptor FGFR1 as a consequence of decreased expression of miR-424 and miR-503, which directly target FGF2 and FGFR1. miR-424 and miR-503 were downregulated in PAH, exerted antiproliferative effects in PAECs and inhibited the capacity of PAEC-conditioned medium to induce the proliferation of pulmonary artery smooth-muscle cells. Reconstitution of miR-424 and miR-503 in vivo ameliorated pulmonary hypertension in experimental models. These studies identify an APLN-dependent miRNA-FGF signaling axis needed for the maintenance of pulmonary vascular homeostasis.

材料
产品编号
品牌
产品描述

Sigma-Aldrich
抗-肌动蛋白, α-平滑肌- Cy3抗体,小鼠单克隆, clone 1A4, purified from hybridoma cell culture
Roche
抗-地高辛-POD,Fab片段, from sheep
Roche
NBT/BCIP 储存液
Sigma-Aldrich
SU 5416, ≥98% (HPLC)